Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

The recall only affects the sensor component of the FreeStyle Libre 3 system, which also includes a reader and an app.

The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...

A Freestyle Libre starter pack, which comes with a reader and two sensors, costs £159.95. Sensors cost £57.95 and need to be replaced every two weeks. After buying a house, she has since started ...

This recall involves removing certain devices from where they are used or sold and does not apply to the FreeStyle Libre 3 reader or app. The FreeStyle Libre 3 Continuous Glucose Monitoring System ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Abbott’s FreeStyle Libre devices involve a small sensor applied ... transmitting the data to a reader or smartphone app. By adding automated insulin delivery technology, the system will be ...

Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

Based on the Ford Five Hundred/Mercury Montego sedan, the Freestyle combines traits of a station wagon and SUV. Front- and all-wheel-drive versions are available. All three rows of seats offer ...